Filing Flows › Claritev (CTEV) › Q1 2026
Claritev (CTEV) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Claritev (CTEV) reported revenue of $245M for the first quarter 2026 (Q1 2026), +6% from a year earlier and -0.8% from the quarter before. Operating margin was 2.7%, net loss $73.6M (30.1% of revenue).
Claritev, Q1 2026: revenue $245M (+6% year over year), operating margin 2.7%, net loss $73.6M, operating cash flow −$45.8M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $245M | -0.8% | +6% |
| Operating profit | $6.6M | — | -32% |
| Net earnings | −$73.6M | — | — |
| Operating cash flow | −$45.8M | -169% | — |
What changed
Revenue was $244.7M in Q1 2026, up 6% year over year and down 1% from the previous quarter. Claims Intelligence Solutions was the largest line at 68% of revenue. Claims Intelligence Solutions added $12.9M year over year (up 8%), 96% of the total change.
Operating profit was $6.6M, a 2.7% margin (down 1.5 points year over year). Operating profit fell $3.1M even though revenue rose $13.3M versus Q1 2025, so costs grew faster than sales. Total costs grew 7% against revenue growth of 6%. The fastest-growing cost line was General & admin (+23%). The quarter ended with a net loss of $73.6M, narrower than the previous quarter's $80.6M loss. Net interest and other expense of $99.4M was the main reason.
Operating cash flow was −$45.8M. Non-cash charges added back $111.1M of depreciation and amortization and $6.9M of share-based compensation. Working capital and other items used $90.2M. Capital expenditures of $46.8M exceeded it, leaving free cash flow of −$92.5M.
Questions
What was Claritev's revenue in the first quarter 2026?
Claritev (CTEV) reported revenue of $245M for the first quarter 2026 (Q1 2026), +6% from a year earlier and -0.8% from the quarter before.
Was Claritev profitable in the first quarter 2026?
Operating profit was $6.6M (2.7% of revenue) and net loss $73.6M.
Source: Claritev 10-Q on SEC EDGAR.